StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Integrated BioPharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Integrated BioPharma's enterprise value was $1.12M on Oct 19, 2026, against $5.87M a year earlier. Over the last 5 years it ranged from -$844.66K to $31.09M, with a median of $6.48M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$1.12M-82.2%
2025Dec 31, 2025$6.29M-18.0%
2024Dec 31, 2024$7.67M+55.6%
2023Dec 29, 2023$4.93M-47.5%
2022Dec 30, 2022$9.40M-69.8%
2021Dec 31, 2021$31.09M+24.1%
2020Dec 31, 2020$25.06M+148.2%
2019Dec 31, 2019$10.10M+23.0%
2018Dec 31, 2018$8.21M-1.4%
2017Dec 29, 2017$8.32M-21.4%
2016Dec 30, 2016$10.59M+61.4%
2015Dec 31, 2015$6.56M-3.2%
2014Dec 31, 2014$6.78M-25.8%
2013Dec 31, 2013$9.14M-1.3%
2012Dec 31, 2012$9.27M–
2011Dec 30, 2011-$303.10K–

More Integrated BioPharma figures

See a number that looks wrong?